Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Phenytoin, free measurement |
Component |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Gingival hypertrophy caused by diphenylhydantoin (disorder) |
Causative agent (attribute) |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
2 |
Accidental overdose of phenytoin |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin blood measurement |
Component |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
2 |
Serum phenytoin measurement |
Component |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
2 |
Accidental phenytoin poisoning (disorder) |
Causative agent (attribute) |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Intentional phenytoin poisoning |
Causative agent (attribute) |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
intoxication par la phénytoïne d'intention indéterminée |
Causative agent (attribute) |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin adverse reaction |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Allergy to phenytoin (finding) |
Causative agent (attribute) |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Phenytoin overdose |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Intentional phenytoin overdose |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
surdose de phénytoïne d'intention indéterminée |
Causative agent (attribute) |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin 6 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Phenytoin 90mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Phenytoin measurement |
Component |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Pentobarbital sodium 390mg/phenytoin sodium 50mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium (substance) |
Is a |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Product containing phenytoin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing phenytoin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing phenytoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Drug-induced lupus erythematosus caused by diphenylhydantoin |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Poisoning by phenytoin |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Accidental phenytoin poisoning (disorder) |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Intentional phenytoin poisoning |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Purple glove syndrome |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Allergy to phenytoin (finding) |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Free phenytoin (substance) |
Is a |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Free phenytoin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Phenytoin sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin 50 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin 18 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin 18 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin 6 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin 6 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely phenytoin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Gingival hypertrophy caused by diphenylhydantoin (disorder) |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
EMPACT (erythema multiforme associated with phenytoin and cranial radiation therapy) syndrome |
Causative agent (attribute) |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin calcium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
|
Serum phenytoin measurement |
Component |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |
Phenytoin blood measurement |
Component |
True |
Phenytoin (substance) |
Inferred relationship |
Some |
1 |